Ftse Mib
38.421,05
0,45%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
96.558,75
0,43%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ProMIS Neurosciences Inc (PMN) ProMIS Neurosciences Inc (PMN) Notizie

ProMIS Neurosciences Inc

PMN
0,815
-0,0851 (-9,45%)
22 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/2/202522:45EDGAR2Form 8-K - Current report
14/2/202523:17EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
12/2/202523:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202513:30GLOBEProMIS Neurosciences to Participate in Guggenheim Securities..
27/1/202513:30EDGAR2Form 8-K - Current report
13/1/202516:30GLOBEProMIS Neurosciences Issues Letter to Shareholders
10/1/202513:29EDGAR2Form 8-K - Current report
10/1/202513:00GLOBEProMIS Neurosciences Initiates Phase 1b Clinical Trial..
08/1/202523:10EDGAR2Form 8-K - Current report
26/11/202413:00GLOBEProMIS Neurosciences to Participate in 7th Annual Evercore..
21/11/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202421:36EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202415:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202415:17EDGAR2Form 8-K - Current report
14/11/202415:15GLOBEProMIS Neurosciences Announces Third Quarter 2024 Financial..
12/11/202413:00GLOBEProMIS Neurosciences to Participate in Guggenheim’s..
06/11/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/10/202413:00GLOBEProMIS Neurosciences Presents Positive Data from PMN310..
24/10/202422:05EDGAR2Form 8-K - Current report
16/10/202422:51EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
10/10/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202422:42EDGAR2Form 8-K - Current report
08/10/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202413:00GLOBEProMIS Neurosciences to Showcase PMN310’s Ability to Target..
09/9/202422:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/9/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
05/9/202413:00GLOBEProMIS Neurosciences to Present at the H.C. Wainwright 26th..
08/8/202413:00GLOBEProMIS Neurosciences Announces Second Quarter 2024 Financial..
06/8/202413:00GLOBEProMIS Neurosciences Announces Data on the Pathogenic Role..
01/8/202413:00GLOBEProMIS Neurosciences to Participate in BTIG Virtual..
30/7/202414:30GLOBEProMIS Neurosciences Showcases Novel Vaccine Approach for..
26/7/202414:35GLOBEProMIS Neurosciences Reports Positive Top-Line Data from its..
26/7/202414:30GLOBEProMIS Neurosciences Announces Up to $122.7 Million Private..
14/6/202422:15EDGAR2Form 8-K - Current report
14/5/202422:25EDGAR2Form 8-K - Current report
14/5/202422:01GLOBEProMIS Neurosciences Announces First Quarter 2024 Financial..
30/4/202413:00GLOBEProMIS Neurosciences Publishes Study Highlighting Oligomer..
09/4/202413:00GLOBEProMIS Neurosciences Publishes in the Journal of Biological..
04/4/202413:00GLOBEProMIS Neurosciences to Present in Upcoming Investor..
01/4/202422:15GLOBEProMIS Neurosciences Announces Full Year 2023 Financial..
11/3/202412:00GLOBEProMIS Neurosciences Strengthens Global Intellectual..
Apertura: 0,90 Min: 0,8011 Max: 0,90
Chiusura: 0,9001

La tua Cronologia

NASDAQ
PMN
ProMIS Neurosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci